Pathophysiological Mechanisms of Takotsubo Cardiomyopathy - a Systematic Review

by Drazen Mlinarevic, Hrvoje Roguljic, Iva Juric, Petra Zebic Mihic, Marul Ivandic, Marko Stupin
Published 2017-04-01

Renal Benefits of SGLT 2 Inhibitors and GLP-1 Receptor Agonists: Evidence Supporting a Paradigm Shift in the Medical Management of Type 2 Diabetes

by Vjera Ninčević, Tea Omanović Kolarić, Hrvoje Roguljić, Tomislav Kizivat, Martina Smolić, Ines Bilić Ćurčić
Published 2019-11-01

Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update

by Hrvoje Roguljic, Hrvoje Roguljic, Hrvoje Roguljic, Vjera Nincevic, Vjera Nincevic, Kristina Bojanic, Kristina Bojanic, Kristina Bojanic, Lucija Kuna, Lucija Kuna, Robert Smolic, Robert Smolic, Aleksandar Vcev, Aleksandar Vcev, Aleksandar Vcev, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Dragan Primorac, Andrijana Vceva, Andrijana Vceva, George Y. Wu, Martina Smolic, Martina Smolic
Published 2021-05-01